Brain and whole-body imaging of nociceptin/orphanin FQ peptide receptor in humans using the PET ligand 11C-NOP-1A

Journal of Nuclear Medicine

Volumn 53, Issue 3, 2012, Pages 385-392

  Lohith, Talakad G ^a   Zoghbi, Sami S ^a   Morse, Cheryl L ^a   Araneta, Maria F ^a   Barth, Vanessa N ^b   Goebl, Nancy A ^b   Tauscher, Johannes T ^b   Pike, Victor W ^a   Innis, Robert B ^a   Fujita, Masahiro ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Nociceptin; NOP receptors; Opioid receptor; PET; Receptor imaging

Indexed keywords

NOCICEPTIN ORPHANIN FQ PEPTIDE RECEPTOR 1A C 11; NOCICEPTIN RECEPTOR; RADIOISOTOPE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; BRAIN RADIOGRAPHY; CEREBELLUM; CONTROLLED STUDY; DOSIMETRY; FEMALE; GALLBLADDER; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE QUALITY; KINETICS; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; RADIATION DOSE; RADIATION EXPOSURE; RADIOACTIVITY; RADIOASSAY; TEMPORAL CORTEX; WHOLE BODY IMAGING;

ADULT; BICYCLO COMPOUNDS, HETEROCYCLIC; BIOTRANSFORMATION; BRAIN; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOTOPE LABELING; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MODELS, STATISTICAL; OPIOID PEPTIDES; POSITRON-EMISSION TOMOGRAPHY; RADIOMETRY; RADIOPHARMACEUTICALS; SPIRO COMPOUNDS; TISSUE DISTRIBUTION; WHOLE BODY IMAGING;

EID: 84858597814     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.097162     Document Type: Article

References (26)

1. Mollereau C, Parmentier M, Mailleux P, et al. ORL1, a novel member of the opioid receptor family: cloning, functional expression and localization. FEBS Lett. 1994;341:33-38.
2. Meunier JC, Mollereau C, Toll L, et al. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 1995;377:532-535.
3. Lambert DG. The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Nat Rev Drug Discov. 2008;7:694-710.
4. Economidou D, Hansson AC, Weiss F, et al. Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat. Biol Psychiatry. 2008;64:211-218.
5. Varty GB, Hyde LA, Hodgson RA, et al. Characterization of the nociceptin receptor (ORL-1) agonist, Ro64-6198, in tests of anxiety across multiple species. Psychopharmacology (Berl). 2005;182:132-143. (Pubitemid 41400870)
6. Ciccocioppo R, Economidou D, Rimondini R, Sommer W, Massi M, Heilig M. Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system. Biol Psychiatry. 2007;61:4-12. (Pubitemid 44855733)
7. Pike VW, Rash KS, Chen Z, et al. Synthesis and evaluation of radioligands for imaging brain nociceptin/orphanin FQ peptide (NOP) receptors with positron emission tomography. J Med Chem. 2011;54:2687-2700.
8. 11C-NOP-1A, a promising PET radioligand for nociceptin/orphanin FQ peptide receptors. J Nucl Med. 2011;52:1638-1645.
9. Gandelman MS, Baldwin RM, Zoghbi SS, Zea-Ponce Y, Innis RB. Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil. J Pharm Sci. 1994;83:1014-1019. (Pubitemid 24228554)
10. 11C-PBR28: a PET radioligand to image inflammation. J Nucl Med. 2007;48:2072-2079.
11. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002;15:273-289. (Pubitemid 34852226)
12. Innis RB, Cunningham VJ, Delforge J, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27:1533-1539. (Pubitemid 47301451)
13. 11C-methyl]-(2)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10:740-747.
14. Ichise M, Toyama H, Innis RB, Carson RE. Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J Cereb Blood Flow Metab. 2002;22:1271-1281.
15. 2 receptors. Synapse. 1999;34:290-304.
16. 3H]-nociceptin ligand-binding and nociceptin opioid receptor mrna expression in the human brain. Neuroscience. 2003;121:629-640.
17. 11C]ethyl-1,3-dihydro-2H-benzimidazol- 2-one as a brain ORL1 receptor imaging agent for positron emission tomography. Nucl Med Biol. 2003;30:51-59.
18. 11C]methyl-Ro 64-6198 as an ORL1 receptor imaging agent. Nucl Med Biol. 2001;28:941-947.
19. 11C-CUMI-101, an agonist radioligand for serotonin-1A receptors in brain. PLoS ONE. 2011;6:e25309.
20. McDonald J, Leonard AD, Serrano-Gomez A, et al. Assessment of nociceptin/orphanin FQ and micro-opioid receptor mRNA in the human right atrium. Br J Anaesth. 2010;104:698-704.
21. Arjomand J, Cole S, Evans CJ. Novel orphanin FQ/nociceptin transcripts are expressed in human immune cells. J Neuroimmunol. 2002;130:100-108. (Pubitemid 35239997)
22. Linari G, Agostini S, Broccardo M, Petrella C, Improta G. Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: a comparative study. Pharmacol Res. 2006;54:356-360. (Pubitemid 44540340)
23. 18F]fluoride ion. Eur J Org Chem. 2008;2853-2873.
24. 18F]fluoride ion with diaryliodonium salts. J Org Chem. 2010;75:3332-3338.
25. 11C]-carfentanil and positron emission tomography (PET). Pain. 2002;99:589-598.
26. Terry G, Liow JS, Chernet E, et al. Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents. Neuroimage. 2008;41:690-698.